Antiva<sup>®</sup>
Antiva®
Adefovir Dipivoxil
Antivirals (Systemic Antifungal, Antiviral and Antiprotozoal Agents)
Indication: Antiva® is indicated for the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.

Dosage & Administration: The recommended dose of Antiva® in chronic hepatitis B patients with adequate renal function is 10 mg, once daily, taken orally, without regard to food.

Preparation: Antiva® Tablet: Each box contains 1 x 10 tablets in blister pack
Other Products From Systemic Antifungal, Antiviral and Antiprotozoal Agents
Amodis<sup>®</sup>
Amodis®

Metronidazole

Antiamoebics & Antianaerobes

Amodis IV Infusion<sup>®</sup>
Amodis IV Infusion®

Metronidazole

Antiamoebics & Antianaerobes

Robic<sup>®</sup>
Robic®

Ornidazole

Antiamoebics & Antianaerobes

Secnid<sup>®</sup>
Secnid®

Secnidazole

Antiamoebics & Antianaerobes

Zox<sup>®</sup>
Zox®

Nitazoxanide

Antiamoebics & Antianaerobes

Itra<sup>®</sup>
Itra®

Itraconazole

Antifungals

Antiva<sup>®</sup>
Antiva®

Adefovir Dipivoxil

Antivirals

Aviflu<sup>®</sup>
Aviflu®

Oseltamivir phosphate

Antivirals

Cavir<sup>®</sup>
Cavir®

Entecavir

Antivirals

Hepavir<sup>®</sup>
Hepavir®

Lamivudine

Antivirals

Revira<sup>TM</sup>
ReviraTM

Valaciclovir

Antivirals

Virux<sup>®</sup>
Virux®

Aciclovir

Antivirals

Fungidal BT<sup>®</sup>
Fungidal BT®

Miconazole Nitrate

Mouth Antifungal

Gelora<sup>®</sup>
Gelora®

Miconazole

Mouth Antifungal

Proxivir<sup>®</sup>
Proxivir®

Tenofovir Disoproxil Fumarate

Antivirals